MedPath
HSA Approval

LACTEOL FORT SACHET

SIN09790P

LACTEOL FORT SACHET

LACTEOL FORT SACHET

May 27, 1998

AMSCO HEALTHCARE MARKETING PTE. LTD.

AMSCO HEALTHCARE MARKETING PTE. LTD.

Regulatory Information

HSA regulatory responsibility and product classification details

Regulatory Responsibility

RegistrantAMSCO HEALTHCARE MARKETING PTE. LTD.
Licence HolderAMSCO HEALTHCARE MARKETING PTE. LTD.

Product Classification

D
Drug Type
Therapeutic
F
Forensic Class
General Sale List
HSA Singapore Classification

Formulation Information

POWDER

Dosage and administration To be taken at the first sign of diarrhoea. ![Lacteol Fort Sachet Dosage Table 1](https://cdn.medpath.com/drug/dosage/20240520/d40a09948a29ecce1fce7f6142771ae3.png) The 2nd dose can be taken 6–8 hours after the 1st dose.

ORAL

Medical Information

Indications Symptomatic treatment of diarrhoea.

A07FA01

lactic acid producing organisms

Manufacturer Information

AMSCO HEALTHCARE MARKETING PTE. LTD.

ADARE PHARMACEUTICALS SAS

Active Ingredients

CULTURE MEDIUM (NEUTRALIZED AND LYOPHILIZED)

160 mg/sachet

LACTOBACILLUS LB (LYOPHILIZED MICROBIAL BODIES)

10 billions/sachet

Documents

Package Inserts

Lacteol Fort Sachet PI.pdf

Approved: October 16, 2018

Download

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.